Joshua A. Israel, MD
Brief Report
Combining Stimulants and Monoamine Oxidase Inhibitors: A Reexamination of the Literature and a Report of a New Treatment Combination
December 10, 2015
The lifetime rate of comorbid major depressive disorder (MDD) in patients diagnosed with attention-deficit/hyperactivity disorder (ADHD) is high, but treating both disorders can be difficult, as worries abound concerning...
